STEPHANIE RITTMAN: Open Payments
NPI 1730851775 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$700 in 29 payments from 11 companies in 2025. Trend: 2023 $243 · 2024 $274 · 2025 $700
Food & beverage: $601Education: $99
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 5 | $163 |
| Astellas Pharma US Inc | 5 | $161 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $105 |
| Biogen, Inc. | 3 | $67 |
| SHIELD THERAPEUTICS INC | 2 | $55 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Organon LLC | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| Dexcom, Inc. | 1 | $24 |
| MILLICENT US INC | 1 | $23 |
Products named: TWIRLA, ZURZUVAE, Veozah, ACCRUFER, SLYND, MYFEMBREE, NEXPLANON, ABRYSVO.
Industry payments across AR — which companies pay providers there.
